Undiagnosed heart disease is a silent killer, but a new application of artificial intelligence is changing how doctors spot hidden risks. Routine chest CT scans,traditionally used to look for lung problems,are now being analyzed to precisely measure indicators of cardiovascular trouble-like calcium buildup in the heart and arteries-rather than simply noting their presence or absence.
Beyond “Yes” or “no”: AI Quantifies Heart Risk
A new approach to reading routine scans could lead to earlier interventions and prevent heart attacks and strokes.
- AI can now quantify heart calcification, aorta calcification, and fat around the heart from standard chest CTs.
- This shift from binary detection to precise measurement allows for more accurate risk assessment.
- Patients already on preventive medications like statins and aspirin showed lower cardiovascular risk with these imaging markers.
- Further research is needed to understand how these quantified markers interact with existing treatments.
This isn’t about finding new problems, itS about seeing old scans in a whole new light. For years, doctors have looked at chest CTs, but often only flagged obvious issues.Now, AI is providing a detailed numerical assessment of cardiovascular health, offering a more nuanced picture of a patient’s risk.
Deepak L. Bhatt MD, FACC and Tzung-Dau Wang, MD, PhD recently discussed “AI-enabled Nationwide Opportunistic Screening of Non-Contrast Chest CT for Death and CV Outcomes,” highlighting the potential of this technology.
The Power of Precision
The key is moving beyond a simple “yes” or “no” diagnosis. Instead of just saying calcium is present in the arteries, the AI provides a specific measurement of the calcium score. This allows clinicians to better stratify risk and tailor treatment plans accordingly. Patients already benefiting from therapies like statins and aspirin demonstrated lower cardiovascular risk when these imaging markers were considered, suggesting a synergistic effect.
Patient Impact-The technology identifies cardiovascular risk earlier and more accurately using existing scans, potentially leading to preventative measures and improved outcomes.
However, researchers emphasize the need for larger, long-term studies. Understanding how these quantified imaging markers interact with medications over time is crucial to optimizing patient care and maximizing the benefits of this innovative approach.
The potential impact is significant. by leveraging existing imaging data,this AI-powered analysis could transform cardiovascular screening and ultimately save lives.
